As compared to previous experiments, here mice were implanted with an increased density of CT26-EphA2 tumor cells to model more aggressive tumors and better discern the combinatorial anticancer effects of anti-PD-1 with photoimmunotherapy. The gene discussed is EPHA2; the disease is neoplasm.